Empagliflzin; significantly attenuates necrosis and prevent left ventricle systolic functions in doxorubicin induced cardiomyopathy via non-antioxidan pathways

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novel Pathways that Regulate Ventricular Function Cardiac Biology and Physiology ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by